PlainRecalls
FDA Drug Critical Class I Terminated

8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx only, Manufactured and Distributed by: Exela Pharma Sciences, LLC Lenoir, NC 28645. Carton NDC 51754-5001-5, vial NDC 51754-5001-1

Reported: November 2, 2022 Initiated: October 4, 2022 #D-0022-2023

Product Description

8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx only, Manufactured and Distributed by: Exela Pharma Sciences, LLC Lenoir, NC 28645. Carton NDC 51754-5001-5, vial NDC 51754-5001-1

Reason for Recall

Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration

Details

Recalling Firm
Exela Pharma Sciences LLC
Units Affected
2,123,040 vials
Distribution
Nationwide within the United States
Location
Lenoir, NC

Frequently Asked Questions

What product was recalled?
8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL Single Dose Vials, packaged in cartons of 20 vials, Rx only, Manufactured and Distributed by: Exela Pharma Sciences, LLC Lenoir, NC 28645. Carton NDC 51754-5001-5, vial NDC 51754-5001-1. Recalled by Exela Pharma Sciences LLC. Units affected: 2,123,040 vials.
Why was this product recalled?
Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration
Which agency issued this recall?
This recall was issued by the FDA Drug on November 2, 2022. Severity: Critical. Recall number: D-0022-2023.